文献リスト

1) Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache. 1982; 22: 66-8

2) Mathew NT, Kurman R, Perez F. Drug induced refractory headache--clinical features and management. Headache. 1990; 30: 634-8

3) Silberstein SD, Lipton RB, Solomon S, et al. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache. 1994; 34: 1-7

4) Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders; 2nd Edition. Cephalalgia. 2004; 24 (suppl 1): 1-160

5) Bigal ME, Tepper SJ, Sheftell FD, et al. Field testing alternative criteria for chronic migraine. Cephalalgia. 2006; 26: 477-82

6) Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: clinical implications. Headache. 2006; 46 Suppl 4: S202- 11

7) Boes CJ, Capobianco DJ. Chronic migraine and medication-overuse headache through the ages. Cephalalgia. 2005; 25: 378-90

8) Pascual J, Colas R, Castillo J. Epidemiology of chronic daily headache. Curr Pain Headache Rep. 2001; 5: 529-36

9) Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004; 3: 475-83

10) Zwart JA, Dyb G, Hagen K, et al. Analgesic use: A predictor of chronic pain and medication overuse headache: The Head-HUNT Study. Neurology. 2003; 61: 160-4

11) Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004; 62: 1338-42

12) Lu SR, Fuh JL, Chen WT, et al. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001; 21: 980-6

13) Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in Chinese elderly: prevalence, risk factors, and biannual follow-up. Neurology. 2000; 54: 314-9

14) Saper JR, Dodick D, Gladstone JP. Management of chronic daily headache: challenges in clinical practice. Headache. 2005; 45 Suppl 1: S74-85

15) Hering-Hanit R, Gadoth N, Cohen A, et al. Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. J Child Neurol. 2001; 16: 448-9

16) Dyb G, Holmen TL, Zwart JA. Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology. 2006; 66: 198-201

17) Wang SJ, Fuh JL, Lu SR, et al. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology. 2006; 66: 193-7

18) Meskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006; 46: 766-72

19) Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982; 33: 335-41

20) Zed PJ, Loewen PS, Robinson G. Medication-induced headache: overview and systematic review of therapeutic approaches. Ann Pharmacother. 1999; 33: 61-72

21) Fritsche G, Eberl A, Katsarava Z, et al. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol. 2001; 45: 229-35

22) Pini LA, Cicero AF, Sandrini M. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001; 21: 878-83

23) Limmroth V, Katsarava Z, Fritsche G, et al. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002; 59: 1011-4

24) Katsarava Z, Limmroth V, Finke M, et al. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology. 2003; 60: 1682-3

25) Katsarava Z, Muessig M, Dzagnidze, A et al. Medication overuse headache: rates and predictors for relapse in a 4-year prospective study. Cephalalgia. 2005; 25: 12-5

26) Saper JR, Hamel RL, Lake AE 3rd. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia. 2005; 25: 545-6

27) Corchs F, Mercante JP, Guendler VZ, et al. Phobias, other psychiatric comorbidities and chronic migraine. Arq Neuropsiquiatr. 2006; 64: 950-3

28) Lake AE 3rd. Placebo, chronic daily headache, and pain: ten points to ponder. Curr Pain Headache Rep. 2006; 10: 4-6

29) Saper JR. Chronic daily headache: a clinician's perspective. Headache. 2002; 42: 538-42

30) Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8 Suppl 7: 1-96

31) Lance F, Parkes C, Wilkinson M. Does analgesic abuse cause headaches de novo？ Headache. 1988; 28: 61-2

32) Bowdler I, Kilian J. The association between analgesic abuse and headache--coincidental or causal. Headache. 1988; 28: 494

33) 国際頭痛分類第2版日本語版. 日本頭痛学会誌. 2004; 31: 13-188. 国際頭痛分類 第2版 新訂増補日本語版. 日本頭痛学会・国際頭痛分類普及委員会訳. 東京: 医学書院; 2007. p. 1-172

34) Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8. 2 Medication-overuse headache. Cephalalgia. 2005; 25: 460-5

35) 五十嵐久佳, 間中信也. 国際頭痛分類第2版第1回改訂版(ICHD-IIR1)における｢8. 2薬物乱用頭痛｣の診断基準の改正点—日本語版国際頭痛分類第2版との相違点. 日本頭痛学会誌. 2006; 33: 26-9

36) Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006; 26: 742-6

37) Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology. 1996; 47: 871-5

38) 竹島多賀夫, 間中信也, 五十嵐久佳, 他. 日本頭痛学会・新国際痛分類普及委員会. 慢性片頭痛と薬物乱用頭痛の付録診断基準の追加について. 日本頭痛学会誌 (印刷中)

39) Saper JR, Lake AE, III. Medication overuse headache: type I and type II. Cephalalgia. 2006; 26: 1262

40) Lake AE, III. Medication overuse headache: biobehavioral issues and solutions. Headache. 2006; 46 Suppl 3: S88-97

41) Trucco M, Meineri P, Ruiz L. Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache. J Headache Pain. 2005; 6: 334-7

42) Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology. 2006; 66: 1894-8

43) Bahra A, Walsh M, Menon S, et al. Does chronic daily headache arise de novo in association with regular use of analgesics？ Headache. 2003; 43: 179-90

44) Zwart JA, Dyb G, Hagen K, et al. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology. 2004; 62: 1540-4

45) Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology. 2006; 67: 109-13

46) Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology. 2004; 63: 2022-7

47) Feinstein AR, Heinemann LA, Dalessio D, et al. Do caffeine-containing analgesics promote dependence？ A review and evaluation. Clin Pharmacol Ther. 2000; 68: 457-67

48) Atasoy HT, Unal AE, Atasoy N, et al. Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache. 2005; 45: 25-31

49) Peterlin BL, Ward T, Lidicker J, et al. A retrospective, comparative study on the frequency of abuse in migraine and chronic daily headache. Headache. 2007; 47: 397-401

50) Scher AI, Lipton RB, Stewart W. Risk factors for chronic daily headache. Curr Pain Headache Rep. 2002; 6: 486-91

51) Srikiatkhachorn A. Chronic daily headache: a scientist's perspective. Headache. 2002; 42: 532-7

52) 竹島多賀夫, 井尻珠美, 福原葉子, 他. 頭痛診療の進歩: 薬剤連用性頭痛とその治療. 神経治療学. 2003; 20: 53-61

53) Boes CJ, Black DF, Dodick DW. Pathophysiology and management of transformed migraine and medication overuse headache. Semin Neurol. 2006; 26: 232-41

54) Knight Y. Brainstem Modulation of Caudal Trigeminal Nucleus: A Model for Understanding Migraine Biology and Future Drug Targets. Headache Currents. 2005; 2: 108-18

55) Welch KM, Nagesh V, Aurora SK, et al. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness？ Headache. 2001; 41: 629-37

56) Aurora SK, Barrodale P, Chronicle EP, et al. Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness. Headache. 2005; 45: 546-52

57) Ayzenberg I, Obermann M, Nyhuis P, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia. 2006; 26: 1106-14

58) de TM, Losito L, Difruscolo O, et al. Changes in cortical processing of pain in chronic migraine. Headache. 2005; 45: 1208-18

59) Fumal A, Laureys S, Di CL, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006; 129: 543-50

60) Peres MF, Zukerman E, Senne Soares CA, et al. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia. 2004; 24: 735-9

61) Sarchielli P, Alberti A, Candeliere A, et al. Glial cell line-derived neurotrophic factor and somatostatin levels in cerebrospinal fluid of patients affected by chronic migraine and fibromyalgia. Cephalalgia. 2006; 26: 409-15

62) Rainero I, Ferrero M, Rubino E, et al. Endocrine function is altered in chronic migraine patients with medication-overuse. Headache. 2006; 46: 597-603

63) Cevoli S, Mochi M, Scapoli C, et al. A genetic association study of dopamine metabolism-related genes and chronic headache with drug abuse. Eur J Neurol. 2006; 13: 1009-13

64) Dobson CF, Tohyama Y, Diksic M, et al. Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia. 2004; 24: 2-11

65) Reuter U, Salomone S, Ickenstein GW, et al. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia. 2004; 24: 398-407

66) Katsarava Z, Fritsche G, Muessig M, et al. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001; 57: 1694-8

67) Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci. 2005; 26: 62-8

68) Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005; 25: 519-22

69) 慢性頭痛治療ガイドライン作成小委員会, 坂井文彦, 荒木信夫, 五十嵐久佳, 他. 日本神経学会治療ガイドライン 慢性頭痛治療ガイドライン2002. 臨床神経. 2002; 42: 330-62

70) 日本頭痛学会, 編. 慢性頭痛の診療ガイドライン. 東京: 医学書院; 2006. p. 1-227

71) Linton-Dahlof P, Linde M, Dahlof C. Withdrawal therapy improves chronic daily headache associated with long-term misuse of headache medication: a retrospective study. Cephalalgia. 2000; 20: 658-62

72) Mathew NT. Amelioration of ergotamine withdrawal symptoms with naproxen. Headache. 1987; 27: 130-3

73) Krymchantowski AV, Moreira PF. Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia. 2003; 23: 982-93

74) Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache. 1991; 31: 71-4

75) Young WB, Silberstein SD. Long-term follow-up of patients treated for chronic headache with analgesic overuse. Cephalalgia. 2001; 21: 873

76) Descombes S, Brefel-Courbon C, Thalamas C, et al. Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache. 2001; 41: 178-82

77) Landy SH, Baker JD. Divalproex ER prophylaxis in migraineurs with probable chronic migraine and probable medication-overuse headache: a case series. Pain Pract. 2004; 4: 292-4

78) Mei D, Ferraro D, Zelano G, et al. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol. 2006; 29: 269-75

79) Borzy JC, Koch TK, Schimschock JR. Effectiveness of topiramate in the treatment of pediatric chronic daily headache. Pediatr Neurol. 2005; 33: 314-6

80) Krymchantowski AV, Barbosa JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia. 2000; 20: 107-13

81) Boe MG, Mygland A, Salvesen R. Prednisolone does not reduce withdrawal headache: a randomized, double-blind study. Neurology. 2007; 69: 26-31

82) Lu SR, Fuh JL, Juang KD, et al. Repetitive intravenous prochlorperazine treatment of patients with refractory chronic daily headache. Headache. 2000; 40: 724-9

83) Smith TR. Low-dose tizanidine with nonsteroidal anti-inflammatory drugs for detoxification from analgesic rebound headache. Headache. 2002; 42: 175-7

84) Silberstein SD, Peres MF, Hopkins MM, et al. Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache. 2002; 42: 515-8

85) Cahill CM, Hardiman O, Murphy KC. Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series. Cephalalgia. 2005; 25: 822-6

86) Relja G, Granato A, Bratina A, et al. Outcome of medication overuse headache after abrupt in-patient withdrawal. Cephalalgia. 2006; 26: 589-95

87) Rossi P, Di Lorenzo C, Faroni J, et al. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006; 26: 1097-105

88) Brighina F, Piazza A, Vitello G, et al. rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study. J Neurol Sci. 2004; 227: 67-71

89) Loder E, Biondi D. General principles of migraine management: the changing role of prevention. Headache. 2005; 45 Suppl 1: S33-47

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp